Brochures
Medical - delivering value through complex product development
With more than 25 years of experience working with clients as an end-end product development partner, Sagentia is well placed to help medical device companies respond to the industry’s challenges. We focus on delivering innovative medical products in four key areas: point of care diagnostics, surgical devices, and patient care.
While the recent economic climate has generally affected most market sectors, cutbacks at hospitals and other healthcare centres, new regulatory policies and changes to reimbursement strategies are having a particularly strong effect on companies in the medical device sector. In parallel, there are growing babyboomer healthcare needs, a marked transition of point of care towards the home environment and a variety of emerging markets to consider. This combination of changing market and user characteristics and increasing cost and price pressures mean that the underlying demand for innovative products and solutions is only going to increase. This innovation will now, more than ever, also need to result in cost effective products that demonstrate higher levels of usability and health effectiveness.
With more than 25 years’ experience working with clients as an end-to-end product development partner, Sagentia is well placed to help medical device companies respond to the industry’s challenges. We focus on delivering innovative medical products in three key areas: point of care diagnostics, surgical devices and patient care. We have delivered innovation and value to a wide range of clients including: Johnson and Johnson, AstraZeneca, St Jude Medical, T2 Biosystems, Titan, Prosurgics and Photocure.
Sagentia co-developed the transmitter, from initial specification through to transfer to manufacture, providing expertise in the selection of low-cost products, consumer product design and electronics and software development.
Sagentia developed the system and its high volume consumable from initial thermal concept and modelling through to transfer to manufacture. In order to meet clinical trial deadlines Sagentia supplemented its standard transfer to production activities with the manufacture and build of the first batch of systems. The system has successfully completed clinical trials and was showcased at Medica in November 2009. It is now being commercialised in countries including India, Brazil and Russia.
Sagentia was involved throughout the design and development of the device for Prosurgics, a venture funded medical device company. Now with FDA and CE approval, the device has provided a range of benefits to surgeons including better image visualisation and reduced camera shake. It is also contributing to improved surgical efficiency through reduced operating times.
Sagentia has more than 25 years experience working with clients as an end-to-end product development partner.